BM | Aksjer | 28,21 M | — | BM BMO | 0,78 | Helsevesen | | 23.1.2023 | 26,39 | 4,17 | 22,59 |
HA | Aksjer | 25,99 M | — | HA Hanwha | 0,40 | Helsevesen | KRX 300 Healthcare Index - KRW - Benchmark TR Gross | 8.11.2018 | 7 972,52 | 4,05 | 49,35 |
XT | Aksjer | 25,41 M | — | XT Xtrackers | 0,35 | Helsevesen | MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index - Benchmark TR Net | 18.1.2023 | 35,36 | 4,42 | 20,67 |
YI | Alternativer | 23,54 M | 52 361 | YI YieldMax | 1,01 | Helsevesen | | 25.9.2025 | 11,08 | 0,00 | 0,00 |
LG | Aksjer | 21,81 M | 1 440 | LG L&G | 0,49 | Helsevesen | Solactive Pharma Breakthrough Value Index | 23.1.2018 | 11,07 | 3,62 | 18,36 |
FU | Aksjer | 20,48 M | — | FU Fubon | 0,60 | Helsevesen | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 3.3.2022 | 0,69 | 0,00 | 0,00 |
JH | Aksjer | 20,34 M | 10 491 | JH John Hancock Investments | 0,40 | Helsevesen | John Hancock Dimensional Healthcare Index | 28.9.2015 | 45,19 | 4,05 | 17,36 |
DI | Aksjer | 19,97 M | 85 376 | DI Direxion | 1,31 | Helsevesen | | 26.3.2025 | 34,73 | 0,00 | 0,00 |
| Aksjer | 19,92 M | 1 683 | GO Goldman | 0,75 | Helsevesen | | 9.11.2021 | 37,94 | 7,30 | 29,06 |
BO | Aksjer | 19,56 M | — | BO Bosera | 0,60 | Helsevesen | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 8.11.2022 | 0,52 | 0,00 | 0,00 |
FT | Aksjer | 18,35 M | 5 527 | FT First Trust | 0,60 | Helsevesen | NYSE Arca Biotechnology Index | 27.5.2020 | 33,37 | 3,45 | 22,71 |
| Aksjer | 17,15 M | 1 880 | HK Horizon Kinetics | 0,85 | Helsevesen | | 27.1.2023 | 36,49 | 5,70 | 22,16 |
PF | Aksjer | 16,16 M | 1 776 | PF Principal Funds | 0,42 | Helsevesen | BTEC-US - No Underlying Index | 22.8.2016 | 39,41 | 4,34 | 0,00 |
DI | Aksjer | 15,8 M | 60 799 | DI Direxion | 1,22 | Helsevesen | S&P Pharmaceuticals Select Industry | 15.11.2017 | 15,05 | 0,00 | 0,00 |
BM | Aksjer | 15,75 M | — | BM BMO | 0,00 | Helsevesen | S&P Health Care Select Sector | 21.1.2025 | 28,20 | 0,00 | 0,00 |
IN | Aksjer | 15,19 M | — | IN Invesco | 0,18 | Helsevesen | S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care Index - Benchmark TR Net | 12.4.2023 | 6,21 | 4,97 | 23,13 |
IN | Aksjer | 14,7 M | 81 | IN Invesco | 0,20 | Helsevesen | STOXX Europe 600 Optimised Health Care Index - EUR | 8.7.2009 | 442,42 | 3,50 | 20,50 |
HE | Aksjer | 14,46 M | — | HE Harvest ETFs | 1,06 | Helsevesen | | 27.2.2020 | 8,37 | 0,00 | 0,00 |
IS | Aksjer | 14,08 M | 2 057 | IS iShares | 0,77 | Helsevesen | | 29.9.2020 | 35,20 | 4,69 | 23,25 |
FT | Aksjer | 13,7 M | 2 336 | FT First Trust | 0,60 | Helsevesen | NYSE Arca Biotechnology Index | 27.5.2020 | 24,90 | 3,45 | 22,71 |
GR | etf_assetclass_Leveraged/Inverse | 13,55 M | — | GR GraniteShares | 8,80 | Helsevesen | Solactive Daily Leveraged 3x long Moderna Index - Benchmark TR Net | 30.8.2021 | 509,01 | 0,00 | 0,00 |
| Aksjer | 13,45 M | — | TA Tachlit | 0,50 | Helsevesen | S&P Health Care Select Sector | 13.11.2018 | 171,70 | 0,00 | 0,00 |
| Aksjer | 12,73 M | 2 147 | RA Range | 0,79 | Helsevesen | Range Oncology Therapeutics Index | 14.10.2015 | 13,68 | 1,22 | 0,00 |
EV | Aksjer | 12,41 M | — | EV Evolve | 0,72 | Helsevesen | Solactive Global Healthcare 20 Index - Benchmark TR Net | 27.11.2019 | 18,28 | 0,00 | 0,00 |
HA | Aksjer | 12,1 M | 6 373 | HA HANetf | 0,89 | Helsevesen | Indxx Advanced Life Sciences & Smart Healthcare Thematic Index | 4.4.2019 | 7,40 | 9,44 | 30,16 |
BM | Aksjer | 11,77 M | 821 | BM BMO | 0,40 | Helsevesen | Solactive Equal Weight U.S Health Care Index - CAD | 12.2.2019 | 53,28 | 3,68 | 20,81 |
GR | etf_assetclass_Leveraged/Inverse | 11,19 M | 68 838 | GR GraniteShares | 1,50 | Helsevesen | | 7.10.2025 | 19,29 | 0,00 | 0,00 |
| Aksjer | 10,99 M | — | TA Tachlit | 0,83 | Helsevesen | S&P Health Care Select Sector | 27.11.2018 | 43,73 | 0,00 | 0,00 |
VA | Aksjer | 10,61 M | — | VA VanEck | 0,00 | Helsevesen | MVIS Global Bionic Healthcare ESG Index - Benchmark TR Net | 2.12.2022 | 18,52 | 3,60 | 27,00 |
TE | Aksjer | 10,28 M | 83 | TE Tema | 0,75 | Helsevesen | | 22.1.2024 | 23,37 | 3,94 | 29,55 |
| Aksjer | 9,97 M | 534 | LO Loncar | 0,79 | Helsevesen | Loncar China BioPharma | 15.8.2018 | 9,77 | 1,73 | 12,13 |
AM | Aksjer | 9,68 M | 1 202 | AM Amplify | 0,68 | Helsevesen | Prime Treatments, Testing and Advancements Index - USD | 18.6.2020 | 19,34 | 2,17 | 13,17 |
FT | etf_assetclass_Sector Equity | 9,6 M | 4 182 | FT First Trust | 0,65 | Helsevesen | NASDAQ Lux Health Tech Index | 22.3.2022 | 24,01 | 4,66 | 26,17 |
JM | etf_assetclass_International Equity | 9,53 M | 373 | JM J.P. Morgan | 0,65 | Helsevesen | | 1.11.2023 | 63,52 | 4,96 | 22,26 |
HO | Aksjer | 9,26 M | — | HO Horizons | 1,63 | Helsevesen | North American Psychedelics Index - CAD | 26.1.2021 | 6,58 | 1,92 | 0,00 |
| Aksjer | 9,1 M | — | IT Itau | 0,00 | Helsevesen | Morningstar US Exponential Technologies Healthcare Index - Benchmark TR Gross | 9.6.2021 | 55,41 | 3,89 | 24,16 |
FT | Aksjer | 8,59 M | 51 | FT First Trust | 0,70 | Helsevesen | StrataQuant Health Care Index | 29.10.2014 | 51,00 | 3,02 | 17,23 |
FI | Aksjer | 8,39 M | 2 781 | FI Fidelity | 0,39 | Helsevesen | Fidelity Digital Health Index | 5.10.2021 | 20,05 | 3,85 | 37,90 |
DE | Aksjer | 8,24 M | 2 447 | DE Defiance | 0,45 | Helsevesen | NASDAQ Junior Biotechnology Index | 3.8.2020 | 29,93 | 5,24 | 0,00 |
BM | Aksjer | 8,13 M | — | BM BMO | 0,00 | Helsevesen | | 26.6.2023 | 18,04 | 0,00 | 0,00 |
GX | Aksjer | 7,47 M | 13 491 | GX Global X | 0,65 | Helsevesen | MSCI China Health Care 10-50 | 11.12.2018 | 12,45 | 2,24 | 15,02 |
| Aksjer | 7,27 M | — | IN Investo | 0,00 | Helsevesen | S&P Biotechnology Select Industry | 15.12.2021 | 59,86 | 0,00 | 0,00 |
IS | Aksjer | 6,26 M | 2 838 | IS iShares | 0,47 | Helsevesen | NYSE FactSet Global Neuro Biopharma and MedTech Index | 24.8.2022 | 31,31 | 4,64 | 16,48 |
GX | Aksjer | 5,96 M | 3 171 | GX Global X | 0,68 | Helsevesen | Solactive Telemedicine & Digital Health Index- TR Net | 17.12.2020 | 10,48 | 3,22 | 29,60 |
RI | Aksjer | 5,85 M | 6 031 | RI Roundhill Investments | 0,99 | Helsevesen | | 3.12.2025 | 48,76 | 0,00 | 0,00 |
AM | Aksjer | 5,68 M | 1 610 | AM Amplify | 0,59 | Helsevesen | VettaFi Weight Loss Drug & Treatment Index - Benchmark TR Net | 21.5.2024 | 24,68 | 5,28 | 19,73 |
| Aksjer | 5,07 M | — | MU Mulvihill | 0,00 | Helsevesen | | 31.1.2023 | 7,73 | 4,06 | 25,89 |
DE | Aksjer | 4,68 M | 7 146 | DE Defiance | 0,75 | Helsevesen | | 27.5.2021 | 5,93 | 0,00 | 0,00 |
| Aksjer | 4,66 M | — | CI CIRCA5000 | 0,49 | Helsevesen | Impak CIRCA5000 Health & Wellbeing Impact Index - Benchmark TR Net | 5.6.2023 | 5,22 | 0,00 | 0,00 |
| etf_assetclass_US Equity | 4,53 M | 15 936 | RE Rexshares | 0,99 | Helsevesen | | 4.11.2025 | 23,85 | 0,00 | 0,00 |
BM | Aksjer | 4,36 M | — | BM BMO | 0,00 | Helsevesen | S&P Health Care Select Sector | 21.1.2025 | 28,54 | 0,00 | 0,00 |
HE | Aksjer | 4,34 M | — | HE Harvest ETFs | 0,00 | Helsevesen | | 21.8.2024 | 8,09 | 0,00 | 0,00 |
CI | Aksjer | 4,3 M | — | CI CI | 0,84 | Helsevesen | | 7.6.2018 | 12,29 | 0,00 | 0,00 |
| Aksjer | 4,16 M | — | KS KSM | 0,00 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 20.11.2018 | 429,28 | 0,00 | 0,00 |
DI | Aksjer | 4,14 M | 4 993 | DI Direxion | 0,99 | Helsevesen | UnitedHealth Group Incorporated | 25.3.2026 | 55,23 | 0,00 | 0,00 |
AN | Aksjer | 3,98 M | 8 882 | AN Anfield | 0,00 | Helsevesen | MarketGrader Global Health Care Leaders Index | 21.9.2021 | 8,91 | 4,00 | 12,63 |
HE | Aksjer | 3,96 M | — | HE Harvest ETFs | 0,00 | Helsevesen | | 15.1.2026 | 6,46 | 0,00 | 0,00 |
TR | Aksjer | 3,96 M | 35 128,46 | TR Tradr | 1,30 | Helsevesen | | 22.10.2025 | 10,41 | 0,00 | 0,00 |
FT | Aksjer | 3,89 M | — | FT First Trust | 0,73 | Helsevesen | NYSE Arca Biotechnology Index | 17.2.2021 | 35,32 | 28,29 | 30,59 |
| Aksjer | 3,78 M | 1 431 | AH ADR hedged | 0,19 | Helsevesen | | 2.1.2025 | 22,26 | 0,00 | 0,00 |
| Aksjer | 3,64 M | — | KE KellyETFs | 0,78 | Helsevesen | NYSE FactSet Global Genomics and Immuno Biopharma Index | 13.1.2022 | 10,37 | 2,86 | 14,62 |
TD | Aksjer | 3,46 M | — | TD TD | 0,45 | Helsevesen | Solactive Global Healthcare Leaders Index | 2.5.2022 | 13,66 | 0,00 | 0,00 |
FT | etf_assetclass_Sector Equity | 3,32 M | 2 504 | FT First Trust | 0,70 | Helsevesen | Indxx Global Medical Equipment Index | 22.6.2021 | 22,13 | 2,93 | 26,01 |
PR | Aksjer | 3,16 M | 8 954 | PR ProShares | 4,53 | Helsevesen | S&P Health Care Select Sector | 30.1.2007 | 13,15 | 0,00 | 0,00 |
DI | Aksjer | 3,13 M | 3 710 | DI Direxion | 6,27 | Helsevesen | NYSE Biotechnology Top 5 Equal Weight Index - Benchmark TR Gross | 1.10.2025 | 41,74 | 0,00 | 0,00 |
DI | Aksjer | 3,13 M | 81 | DI Direxion | 0,00 | Helsevesen | BITA Messenger RNA Technology Index - Benchmark TR Net | 9.12.2021 | 13,76 | 3,69 | 0,00 |
FT | Aksjer | 3,07 M | 12 | FT Franklin Templeton | 0,30 | Helsevesen | Solactive Sustainable Health and Wellness Index | 5.7.2023 | 30,67 | 3,22 | 18,08 |
DI | Aksjer | 3,06 M | 18 827 | DI Direxion | 1,99 | Helsevesen | Eli Lilly and Co. - USD - Benchmark Price Return | 26.3.2025 | 20,42 | 0,00 | 0,00 |
FT | Aksjer | 3,04 M | — | FT Franklin Templeton | 0,30 | Helsevesen | Solactive Sustainable Health and Wellness Index | 5.7.2023 | 30,32 | 3,22 | 18,08 |
FT | Aksjer | 3,04 M | — | FT Franklin Templeton | 0,30 | Helsevesen | Solactive Sustainable Health and Wellness Index | 5.7.2023 | 30,32 | 3,22 | 18,08 |
GX | Aksjer | 3,01 M | 725 | GX Global X | 0,65 | Helsevesen | Cboe S&P Health Care Select Sector Half BuyWrite Index - Benchmark TR Gross | 23.11.2022 | 25,10 | 5,04 | 27,46 |
FI | Aksjer | 2,89 M | — | FI Fidelity | 0,50 | Helsevesen | Fidelity Digital Health ESG Tilted Index - Benchmark TR Net | 24.8.2022 | 5,42 | 0,00 | 0,00 |
FT | Aksjer | 2,88 M | — | FT First Trust | 0,82 | Helsevesen | StrataQuant Health Care Index - CAD | 8.12.2017 | 28,81 | 0,00 | 0,00 |
| Aksjer | 2,78 M | — | TA Tachlit | 0,30 | Helsevesen | NASDAQ / Biotechnology | 27.11.2018 | 30,55 | 0,00 | 0,00 |
GX | Aksjer | 2,71 M | — | GX Global X | 0,00 | Helsevesen | VettaFi Equal Weight Global Healthcare Index - CAD - Benchmark TR Net | 30.4.2025 | 21,64 | 0,00 | 0,00 |
| Aksjer | 2,59 M | 5 044 | KE KellyETFs | 0,78 | Helsevesen | Strategic CRISPR & Gene Editing Technology Index - Benchmark TR Gross | 13.1.2022 | 7,38 | 1,68 | 17,02 |
DE | Aksjer | 2,58 M | 47 567 | DE Defiance | 1,51 | Helsevesen | | 18.8.2025 | 5,17 | 0,00 | 0,00 |
| Aksjer | 2,56 M | 3 729 | LA Langar | 0,85 | Helsevesen | | 9.1.2024 | 11,13 | 3,48 | 25,34 |
CI | Aksjer | 2,33 M | — | CI CI | 0,85 | Helsevesen | | 3.3.2022 | 9,28 | 0,00 | 0,00 |
HO | Aksjer | 2,03 M | — | HO Horizons | 1,19 | Helsevesen | Solactive Global Vaccines and Infectious Diseases Index - CAD - Benchmark TR Net | 26.10.2021 | 15,47 | 0,00 | 0,00 |
HE | Aksjer | 2,03 M | — | HE Harvest ETFs | 0,00 | Helsevesen | | 15.1.2026 | 13,49 | 0,00 | 0,00 |
PU | Aksjer | 1,93 M | — | PU Purpose | 1,27 | Helsevesen | | 4.10.2021 | 19,26 | 4,48 | 18,17 |
| Aksjer | 1,91 M | 21 608 | PS PSYK | 0,75 | Helsevesen | Enhanced Consciousness Index - Benchmark TR Net | 31.1.2022 | 16,46 | 2,18 | 0,00 |
PR | Aksjer | 1,9 M | 8 597 | PR ProShares | 3,91 | Helsevesen | NASDAQ / Biotechnology | 7.4.2010 | 11,47 | 0,00 | 0,00 |
KR | Aksjer | 1,9 M | 129 | KR KraneShares | 0,79 | Helsevesen | Solactive Emerging Markets Healthcare Index NTR | 28.8.2018 | 18,99 | 3,09 | 26,95 |
| Aksjer | 1,84 M | 12 202 | LE LeverageShares | 0,75 | Helsevesen | iSTOXX Leveraged 3x MRNA Index - Benchmark TR Net | 14.12.2021 | 95,85 | 0,00 | 0,00 |
BE | Aksjer | 1,68 M | — | BE BetaShares | 0,67 | Helsevesen | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net | 30.3.2022 | 10,54 | 3,36 | 39,43 |
GR | etf_assetclass_Leveraged/Inverse | 1,68 M | 877 | GR GraniteShares | 3,24 | Helsevesen | Solactive Daily Leveraged 3x long BP Index | 4.11.2019 | 26,60 | 0,00 | 0,00 |
DE | Aksjer | 1,54 M | 87 899 | DE Defiance | 1,29 | Helsevesen | | 2.9.2025 | 8,55 | 0,00 | 0,00 |
| Aksjer | 1,5 M | 4 380 | AD ADRhedged | 0,19 | Helsevesen | AstraZeneca PLC - Benchmark Price Return | 7.10.2024 | 50,52 | 0,00 | 0,00 |
KR | Aksjer | 1,5 M | 484 | KR KraneShares | 0,65 | Helsevesen | MSCI China All Shares Health Care 10/40 Index | 14.1.2021 | 9,98 | 2,55 | 19,00 |
GX | Aksjer | 1,41 M | 712 | GX Global X | 0,65 | Helsevesen | Solactive China Biotech Innovation Index | 25.9.2020 | 6,72 | 2,41 | 18,61 |
HE | Aksjer | 1,37 M | — | HE Harvest ETFs | 0,00 | Helsevesen | | 21.8.2024 | 8,98 | 0,00 | 0,00 |
HO | Aksjer | 1,1 M | — | HO Horizons | 0,89 | Helsevesen | Solactive Telemedicine & Digital Health Index- TR Net | 2.11.2021 | 18,30 | 0,00 | 0,00 |
BM | Aksjer | 1,09 M | — | BM BMO | 0,00 | Helsevesen | | 9.2.2026 | 42,86 | 0,00 | 0,00 |
AI | Aksjer | 892 679 | 163 | AI AXS Investments | 1,15 | Helsevesen | Pfizer Inc. | 13.7.2022 | 51,63 | 0,00 | 0,00 |
GR | Alternativer | 889 959 | 5 046 | GR GraniteShares | 1,07 | Helsevesen | | 2.12.2025 | 5,24 | 0,00 | 0,00 |
BF | Aksjer | 856 049 | — | BF Brompton Funds | 0,75 | Helsevesen | | 8.8.2019 | 8,78 | 0,00 | 0,00 |
| Aksjer | 800 500 | 1 254 | LE LeverageShares | 0,75 | Helsevesen | | 18.12.2025 | 32,02 | 0,00 | 0,00 |
| Aksjer | 720 170 | 384 | AH ADR hedged | 0,17 | Helsevesen | GSK plc - Benchmark Price Return | 3.1.2025 | 72,01 | 0,00 | 0,00 |